Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
114 pending office actions • 90 clients • 106 examiners • 67 art units • 0 of 114 (0%) have an AI response strategy ready
ICE MILLER LLP specializes in the Biotechnology & Pharmaceuticals technology area. The firm has handled 4316 career applications, demonstrating extensive experience navigating the specific legal and technical hurdles of the life sciences sector. Its resolved allowance rate pct of 84.17 provides a clear metric for its historical success in securing patent grants for its clients. This rate reflects the firm's capability in a field known for rigorous examination standards.
The firm is currently handling 94 pending office actions, indicating a steady flow of active prosecution work. The firm averages 3.24 avg office actions per allowance, which suggests a rigorous examination process that often requires multiple responses to the patent office. This 3.24 avg office actions per allowance, combined with the 84.17 resolved allowance rate pct, characterizes the firm's persistent approach to securing grants for its 4316 career applications. For practitioners, these metrics provide a baseline for evaluating the firm's performance and the typical prosecution timeline in Biotechnology & Pharmaceuticals.
Based on the USPTO statutory response window for each pending office action. 37 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 37 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (3%) |
| §101 + other | 22 (19%) |
| §103 only | 20 (18%) |
| §102 only | 3 (3%) |
| §112 only | 10 (9%) |
| Double-patenting only | 2 (2%) |
| Double-patenting + other | 12 (11%) |
| Multi-statute (no §101) | 42 (37%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZEROUAL, OMAR | 4 | 33.5% | +39.7% |
| HOFFA, ANGELA MARIE | 3 | 67.6% | +28.3% |
| WEDDINGTON, KEVIN E | 2 | 75.2% | +9.8% |
| NEAGU, IRINA | 2 | 46.8% | +57.3% |
| THOMPSON, CURTIS A | 2 | 60.8% | +52.7% |
| DO, NHAT CHIEU Q | 1 | 64.0% | +48.9% |
| NELSON, KERI JESSICA | 1 | 58.5% | +41.2% |
| GARCIA-GUERRA, DARLENE | 1 | 23.3% | +34.3% |
| SKROBARCZYK III, ROBERT ANTHONY | 1 | 16.7% | +16.3% |
| HSU, JONI | 1 | 87.7% | +7.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18635402 | INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) | AULAKH, CHARANJIT | 475d overdue |
| 18793346 | SYSTEMS AND METHODS FOR AUTOMATED PREDICTION OF INSIGHTS FOR VENDOR PRODUCT ROADMAPS | ZEROUAL, OMAR | 147d overdue |
| 17757801 | PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF | LEE, SIN J | 73d overdue |
| 18729134 | STATISTICAL DATA ACQUISITION DEVICE, DEGREE OF CONTRIBUTION CALCULATION DEVICE, TREATMENT ACTION SEARCH DEVICE, TREATMENT OBJECT SEARCH DEVICE, STATISTICAL DATA ACQUISITION PROGRAM, DEGREE OF CONTRIBUTION CALCULATION PROGRAM, TREATMENT ACTION SEARCH PROGRAM, AND TREATMENT OBJECT SEARCH PROGRAM | LEE, ANDREW ELDRIDGE | 72d overdue |
| 18127221 | DIFFUSER SECURED TO CONTAINER DRAWING OIL FRAGRANCE INTO DIFFUSER ELEMENT VIA CAPILLARY ACTION | PHAM, TUONGMINH NGUYEN | 32d overdue |
| 18837498 | FIBRE CEMENT PLATE AND A WALL STRUCTURE HAVING THE FIBRE CEMENT PLATES | ADAMOS, THEODORE V | 15d overdue |
| 18494851 | Method of using a handheldable pulling and compressing device for repair of motor vehicle components | KAKARLA, BHASKAR | 9d overdue |
| 18174463 | FIBER ARRAYS | ALABI, OYELEYE A | 8d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18793346 | SYSTEMS AND METHODS FOR AUTOMATED PREDICTION OF INSIGHTS FOR VENDOR PRODUCT ROADMAPS | ZEROUAL, OMAR | 147d overdue |
| 18568031 | USE OF MMP INHIBITORS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME | NEAGU, IRINA | 9d overdue |
| 18568043 | SAFE USE OF MMP-12 INHIBITOR | NEAGU, IRINA | 9d overdue |
| 17260000 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | THOMPSON, CURTIS A | 5d overdue |
| 17259992 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | THOMPSON, CURTIS A | 5d overdue |
| 18949952 | SYSTEMS AND METHODS FOR INTEGRATING REAL-TIME BUSINESS INSIGHTS | ZEROUAL, OMAR | 34d |
| 19558117 | HIGH STIFFNESS BOOSTER WITH COMPLIANT SUPPORT TABS AT NODE OR ANTINODE POSITIONS AND ULTRASONIC WELDING APPARATUS INCLUDING SAME | DO, NHAT CHIEU Q | — |
| 19533974 | Frame | NELSON, KERI JESSICA | — |
| Art Unit | Apps |
|---|---|
| 1629 | 5 |
| 3628 | 4 |
| 1621 | 4 |
| 1798 | 3 |
| 3629 | 2 |
| 1627 | 2 |
| 1651 | 2 |
| 1643 | 2 |
| 1675 | 2 |
| 1797 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19558117 | HIGH STIFFNESS BOOSTER WITH COMPLIANT SUPPORT TABS AT NODE OR ANTINODE POSITIONS AND ULTRASONIC WELDING APPARATUS INCLUDING SAME | Dukane Ias, LLC | DO, NHAT CHIEU Q | 3724 | §102§103§112DP | Final Rejection | — | Pending | Mar 05, 2026 |
| 19533974 | Frame | Mosaic Surgical Limited | NELSON, KERI JESSICA | 3786 | §102§103DPOther | Non-Final OA | — | Pending | Feb 09, 2026 |
| 19399360 | SYSTEMS AND METHODS FOR SUPPLY CHAIN MANAGEMENT INCLUDING ERP AGNOSTIC REALTIME DATA MESH WITH CHANGE DATA CAPTURE | Ingram Micro Inc. | ZEROUAL, OMAR | 3629 | §101§103 | Non-Final OA | — | Pending | Nov 24, 2025 |
| 19294170 | METHOD AND SYSTEM FOR PROVIDING TECHNICAL SERVICE TO AN AGRICULTURAL WORKING MACHINE | Claas Omaha Inc. | GARCIA-GUERRA, DARLENE | §101§103§112 | Non-Final OA | — | Pending | Aug 07, 2025 | |
| 19171105 | METHODS OF ENHANCING STEM CELL PRODUCTION | All-Cells Healing, Inc. | SKROBARCZYK III, ROBERT ANTHONY | §101§112 | Non-Final OA | — | Pending | Apr 04, 2025 | |
| 19088739 | METHOD AND SYSTEM OF A COMMAND BUFFER BETWEEN A CPU AND GPU | Oxide Interactive, Inc. | HSU, JONI | §103Other | Non-Final OA | — | Pending | Mar 24, 2025 | |
| 19085265 | METHODS TO TREAT LONG-COVID AND INFLUENZA | Tesla Biohealing, LLC | HOFFA, ANGELA MARIE | §101§112 | Non-Final OA | — | Pending | Mar 20, 2025 | |
| 19043248 | METHODS TO TREAT PARKINSON'S DISEASE | Brain Healing Inc. | HOFFA, ANGELA MARIE | §101§112 | Non-Final OA | — | Pending | Jan 31, 2025 | |
| 19043212 | METHODS TO TREAT GENE MUTATION AND MUSCULAR DEGENERATIVE DISEASE | All-Cells Healing Inc. | HOFFA, ANGELA MARIE | §101§112 | Non-Final OA | — | Pending | Jan 31, 2025 | |
| 19009885 | METHODS TO MITIGATE SIDE EFFECTS OF CANCER TREATMENTS | All-Cells Healing Inc. | SISON, CHRISTINE ANDREA PAN | §101§112 | Non-Final OA | — | Pending | Jan 03, 2025 | |
| 18880475 | COMBINATION THERAPIES INVOLVING L-ASPARAGINASE | Jazz Pharmaceuticals Ireland Limited | PAK, YONG D | §102§103§112 | Non-Final OA | — | Pending | Dec 31, 2024 | |
| 19005365 | AUTOMATED MULTI-PARTY DOCUMENT MANAGEMENT PLATFORM AND USER INTERACTIVE TOOL | Citizens Financial Group, Inc. | WALTON, CHESIREE A | 3624 | §101§103 | Non-Final OA | — | Pending | Dec 30, 2024 |
| 19003616 | SYSTEM AND METHOD FOR PAYROLL RECONCILIATION AND PAYMENT | Salus Finance, LLC | NOVAK, REBECCA R | 3629 | §101§103 | Final Rejection | — | Pending | Dec 27, 2024 |
| 19002457 | DATA RESTORE SYSTEM | Druva Inc. | GUYTON, PHILIP A | 2113 | §101 | Non-Final OA | 3d overdue | Pending | Dec 26, 2024 |
| 18985291 | ANTI-THEFT DEVICE FOR A TRANSPORT RAILCAR GRATING | Holden America Il, LLC | MCCARRY JR, ROBERT J | §102 | Non-Final OA | — | Pending | Dec 18, 2024 | |
| 18971858 | LOW PROFILE HOLLOW RETROREFLECTOR ASSEMBLY AND THEIR MOUNTING STRUCTURES AND MOUNTING METHODS | Plx, Inc. | RAKOWSKI, CARA E | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2024 | |
| 18949952 | SYSTEMS AND METHODS FOR INTEGRATING REAL-TIME BUSINESS INSIGHTS | Ingram Micro Inc. | ZEROUAL, OMAR | 3628 | §101§103§112 | Final Rejection | 34d | Pending | Nov 15, 2024 |
| 18938440 | GUANIDINOACETIC ACID, ITS DERIVATES, COMPOSITIONS AND METHODS OF USE THEREOF | Christopher Stahley | ARCORIA, PAUL JOSEPH | §103§112 | Non-Final OA | — | Pending | Nov 06, 2024 | |
| 18936975 | LAYERED, OBJECT SPACE, PROGRAMMABLE AND ASYNCHRONOUS SURFACE PROPERTY GENERATION SYSTEM | Oxide Interactive, Inc. | CRAWFORD, JACINTA M | DP | Non-Final OA | — | Pending | Nov 04, 2024 | |
| 18853244 | IMMUNE ENHANCEMENT OF CANCER TREATMENT | Institut D'Investigacions Biomédiques August Pi I Sunyer (Idibaps) | ABBAS, ABDULRAHMAN MUSTAFA | §103§112 | Non-Final OA | — | Pending | Oct 01, 2024 | |
| 18895049 | THORACOSTOMY DEVICE | Ohiohealth Corporation | MARCETICH, ADAM M | §112DP | Non-Final OA | — | Pending | Sep 24, 2024 | |
| 18828450 | MULTI-MODAL DEVELOPMENT INTERFACE FOR LARGE LANGUAGE MODEL APPLICATIONS | Gopal Datt Joshi | O'CONNOR-EMANUEL, LAWRENCE SCOTT | §101§102§103§112 | Non-Final OA | — | Pending | Sep 09, 2024 | |
| 18844879 | METHOD AND SYSTEM FOR LEAKAGE DETECTION IN A FLUID SYSTEM | Grundfos Holding A/S | BOLDUC, DAVID J | §101§102§103 | Non-Final OA | — | Pending | Sep 06, 2024 | |
| 18843180 | SYSTEM AND METHOD FOR TREATMENT BY ELECTROPHYSIOLOGICAL STIMULATION | TrueRelief, LLC | ALTER MORSCHAUSER, ALYSSA MARGO | §103Other | Non-Final OA | — | Pending | Aug 30, 2024 | |
| 18817538 | SYSTEMS AND METHODS FOR STANDARDIZING DEFINITION OF SOFTWARE ARCHITECTURES | Facets Cloud Inc. | MITCHELL, JASON D | §101§102§103§112 | Non-Final OA | — | Pending | Aug 28, 2024 | |
| 18810352 | LIPID COMPOUND, LIPID NANOPARTICLE COMPRISING SAME AND USE THEREOF | Themedium Therapeutics Co., Ltd. | ARNOLD, ERNST V | §102§103§112DP | Non-Final OA | — | Pending | Aug 20, 2024 | |
| 18837498 | FIBRE CEMENT PLATE AND A WALL STRUCTURE HAVING THE FIBRE CEMENT PLATES | Swisspearl Danmark Holding A/S | ADAMOS, THEODORE V | 3635 | §102§103 | Non-Final OA | 15d overdue | Pending | Aug 09, 2024 |
| 18794654 | KINETIC CARRIER DEVICE | Degrees Of Freedom LLC | CASTELLANO, STEPHEN J | 3733 | §102§112 | Final Rejection | 62d | Pending | Aug 05, 2024 |
| 18793346 | SYSTEMS AND METHODS FOR AUTOMATED PREDICTION OF INSIGHTS FOR VENDOR PRODUCT ROADMAPS | Ingram Micro Inc. | ZEROUAL, OMAR | 3628 | §101§112 | Final Rejection | 147d overdue | Pending | Aug 02, 2024 |
| 18775244 | ADJUSTABLE FLOW URINARY CATHETER | Rethink Medical, S.L. | LEVY, BRANDON WILLIAM | §102§103§112 | Non-Final OA | — | Pending | Jul 17, 2024 | |
| 18729134 | STATISTICAL DATA ACQUISITION DEVICE, DEGREE OF CONTRIBUTION CALCULATION DEVICE, TREATMENT ACTION SEARCH DEVICE, TREATMENT OBJECT SEARCH DEVICE, STATISTICAL DATA ACQUISITION PROGRAM, DEGREE OF CONTRIBUTION CALCULATION PROGRAM, TREATMENT ACTION SEARCH PROGRAM, AND TREATMENT OBJECT SEARCH PROGRAM | Aizoth Inc. | LEE, ANDREW ELDRIDGE | 3684 | §101§102§103 | Final Rejection | 72d overdue | Pending | Jul 15, 2024 |
| 18768971 | SYSTEMS AND METHODS FOR DISTRIBUTION MANAGEMENT INCLUDING SPECIAL PRICING DETERMINATION | Ingram Micro Inc. | NELSON, FREDA ANN | 3628 | §101§112 | Final Rejection | 60d | Pending | Jul 10, 2024 |
| 18727456 | SILICONE GEL COMPOSITION OF WALNUT EXTRACT | Hartington Business, S. L. | MOEHLMAN, ANDREW TERRY | 1655 | §103§112 | Non-Final OA | — | Pending | Jul 09, 2024 |
| 18752716 | HAND-HELD PULLING AND COMPRESSION DEVICE AND MODULAR SYSTEM | Tkr Spezialwerkzeuge GmbH | SONG, HIMCHAN | §112 | Non-Final OA | — | Pending | Jun 24, 2024 | |
| 18752705 | HAND-HELD PULLING AND COMPRESSION DEVICE AND MECHANICAL FORCE AMPLIFIER | Tkr Spezialwerkzeuge GmbH | LONG, ROBERT FRANKLIN | 3731 | §112 | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18723323 | METHOD AND KIT FOR TREATING A DAMAGED CONNECTIVE TISSUE | Reddress Ltd. | PEEBLES, KATHERINE | 1617 | §103§112DP | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18722532 | RELIABLE OPTICAL TRANSIT TIME METHOD FOR DETERMINING DISTANCE VALUES | K.A. Schmersal Holding GmbH & Co. Kg | WOLDEMARYAM, ASSRES H | §102§103§112 | Non-Final OA | — | Pending | Jun 20, 2024 | |
| 18577053 | SMALL MOLECULE COMPOUND TARGETING BCL9/BETA-CATENIN INTERACTION | Nantong Jutai Biotech Co., Ltd. | KOSTURKO, GEORGE W | §102§103§112 | Non-Final OA | — | Pending | Jun 06, 2024 | |
| 18735463 | BIOENERGY (BIOPHOTON) GENERATOR AND ITS USE | Tesla Biohealing, Inc. | TRUONG, QUANGLONG N | 1615 | §103 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18716469 | METHOD AND APPARATUS FOR DETECTING HYDRAULIC SHOCK | Grundfos Holding A/S | TIMILSINA, SHARAD | 2853 | §103§112 | Non-Final OA | — | Pending | Jun 04, 2024 |
| 18714054 | HANDHELD PULLING AND COMPRESSING DEVICE | Tkr Spezialwerkzeuge GmbH | WILSON, LEE D | 3723 | §102 | Final Rejection | — | Pending | May 28, 2024 |
| 18712989 | DAROLUTAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | Sinotherapeutics Inc. | PARK, HAEJIN S | 1614 | §102§103§112 | Non-Final OA | — | Pending | May 23, 2024 |
| 18701612 | MULTI-LAYERED MATERIAL, IN PARTICULAR FOR HYGIENE/SANITARY PRODUCTS, AND MANUFACTURING METHOD FOR MAKING SUCH A MULTI-LAYERED MATERIAL | Fitesa Sulmona S.r.l. | PHAM, KATHERINE-PH MINH | 3781 | §103§112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18635402 | INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) | Medic Life Sciences Inc. | AULAKH, CHARANJIT | 1621 | §102§112Other | Non-Final OA | 475d overdue | Pending | Apr 15, 2024 |
| 18697846 | One-Step Method for Synthesis of Circular RNA | Suzhou Abogen Biosciences Co., Ltd. | GROOMS, TIFFANY NICOLE | §102§103§112 | Non-Final OA | — | Pending | Apr 02, 2024 | |
| 18599752 | ENHANCED NO-CODE ETL SYSTEM FOR AUTOMATED BIG DATA TRANSFORMATION AND SHARING | Cloudblue LLC | CHOI, YUK TING | 2164 | §103§112 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18264949 | COMPOUND SERVING AS NLRP3 INHIBITOR | Hangzhou Innogate Pharma Co., Ltd. | WEDDINGTON, KEVIN E | 1629 | §112Other | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18687250 | SCREEN EQUIPPED ITEM IDENTIFICATION USING INDICIA | UNEFI INC. | XIE, THEODORE L | 3623 | §102§103§112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18683332 | METHOD AND DEVICE FOR ABSOLUTE QUANTIFICATION OF ANALYTES | Cenios GmbH | XING, CHRISTINA ILONA | 2877 | §103§112 | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18682647 | SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | NESTOR, DONNA MICHELLE | 1627 | §103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18260303 | LONG-ACTING INTERLEUKIN-15 FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Suzhou Forlong Biotechnology Co., Ltd. | ESSEX, LAURA ANN | §102§103§112 | Non-Final OA | — | Pending | Jan 31, 2024 | |
| 18405848 | CUSHION CONFIGURED TO BE SECURED TO AN EAR CUP OF A HEADSET AND/OR HEARING PROTECTION DEVICE | Invisio A/S | ANWAH, OLISA | 2692 | §112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18574513 | PROCESSES FOR THE PREPARATION OF NON-STEROIDAL ANTIANDROGENS | Química Sintética, S.A. | NOTTINGHAM, KYLE GREGORY | 1621 | §103§112 | Final Rejection | 21d | Pending | Dec 27, 2023 |
| 18571461 | Acylated Insulin-Containing Pharmaceutical Composition | Gan & Lee Pharmaceuticals Co., Ltd. | COFFA, SERGIO | 1658 | §103§112DP | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18541329 | INTERACTIVE DATA MODELING AND COMMUNICATION PLATFORM | Citizens Financial Group, Inc. | CHEN, ALAN S | §103§112 | Non-Final OA | — | Pending | Dec 15, 2023 | |
| 18570783 | N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF | Shanghai Leado Pharmatech Co., Ltd. | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18569933 | SYSTEM AND METHOD FOR MOBILE AND STATIONARY COMPUTING DEVICE INTERWORKING | Simpleway Technologies Ltd. | JUNG, ANDREW J | 2175 | §103 | Final Rejection | 261d overdue | Pending | Dec 13, 2023 |
| 18568031 | USE OF MMP INHIBITORS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME | Foresee Pharmaceuticals Usa, Inc. | NEAGU, IRINA | 1629 | §103Other | Non-Final OA | 9d overdue | Pending | Dec 07, 2023 |
| 18568043 | SAFE USE OF MMP-12 INHIBITOR | Yuhua Li | NEAGU, IRINA | 1629 | §103DP | Final Rejection | 9d overdue | Pending | Dec 07, 2023 |
| 18565763 | ENERGY EFFICIENT SEPARATION OF POLYOLEFINS | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | BOYKIN, TERRESSA M | §103 | Non-Final OA | — | Pending | Nov 30, 2023 | |
| 18565418 | Combined Learner Forming Apparatus, Combined Learner Forming Program, and Non-Transitory Recording Medium Storing Combined Lerner Forming Program | Aizoth Inc. | RUTTEN, JAMES D | §101§102§103 | Non-Final OA | — | Pending | Nov 29, 2023 | |
| 18260412 | POLYNUCLEOTIDE AND EXPRESSION CASSETTE COMPRISING CODING SEQUENCE OF TOLUENE DIOXYGENASE, AND USE THEREOF | Zhejiang Boxiao Biopharmaceutical Co., Ltd. | YU, DELPHINUS DOU YI | 1651 | §103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18509650 | PYROELECTRIC INFRARED DETECTOR DEVICE | Photona GmbH | FAYE, MAMADOU | 2884 | §103 | Final Rejection | — | Pending | Nov 15, 2023 |
| 18560566 | Nutritional Compositions for Preserving Muscle Mass | Dutch Medical Food B.V. | MCCLAIN, TYNESHA L. | 1793 | §101§103 | Final Rejection | — | Pending | Nov 13, 2023 |
| 18495029 | DATA INTELLIGENCE PLATFORM | Citizens Financial Group, Inc. | MUSTAFA, MOHAMMED H | 3693 | §101 | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18494851 | Method of using a handheldable pulling and compressing device for repair of motor vehicle components | Tkr Spezialwerkzeuge GmbH | KAKARLA, BHASKAR | 2116 | §103§112 | Non-Final OA | 9d overdue | Pending | Oct 26, 2023 |
| 18494069 | COMPOSITE SOLID-STATE ELECTROLYTE AND LITHIUM BATTERIES USING THE SAME | Natrion Inc. | WYLUDA, KIMBERLY | §103 | Non-Final OA | — | Pending | Oct 25, 2023 | |
| 18493764 | SCALABLE REPORTING SYSTEM FOR SECURITY ANALYTICS | Cloudblue LLC | SAVENKOV, VADIM | 2432 | §101§103§112 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18032930 | SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Shanghai Zelgen Pharma.Tech Co., Ltd. | WEDDINGTON, KEVIN E | 1629 | §112 | Non-Final OA | — | Pending | Oct 23, 2023 |
| 18556605 | Validating Elements Displayed on a Display Fixture | UNEFI INC. | BAGGOT, BREFFNI | 3621 | §101 | Final Rejection | 28d | Pending | Oct 20, 2023 |
| 18285209 | FORMULATIONS OF L-ASPARAGINASE | Jazz Pharmaceuticals Ireland Limited | PAGUIO FRISING, MICHELLE F | 1651 | §102 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18550008 | Methods of Identifying Active Lupus Nephritis Flare | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | SITTON, JEHANNE SOUAYA | 1682 | §101§102§103 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18463454 | Anti-CD28 Humanized Antibodies Formulated for Administration to Humans | Ose Immunotherapeutics | DENT, ALANA HARRIS | 1643 | §102§103 | Final Rejection | — | Pending | Sep 08, 2023 |
| 18546555 | PTC Heating Element, Electric Heating Device and Use of a PTC Heating Element | TDK Electronics AG | MACEDA, KRYSTENE NHE BANDONG | 3761 | §103§112 | Final Rejection | — | Pending | Aug 15, 2023 |
| 18276342 | PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Minghui Pharmaceutical (Shanghai) Limited | O DELL, DAVID K | 1621 | §102§103§112 | Final Rejection | 2d overdue | Pending | Aug 08, 2023 |
| 18264671 | DIHYDROPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Visonpharma Co., Ltd. | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | §103 | Final Rejection | 70d overdue | Pending | Aug 08, 2023 |
| 18350055 | SYSTEMS AND METHODOLOGIES FOR AUTO LABELING VULNERABILITIES | Cloudblue LLC | KNACKSTEDT, JACOB BENEDICT | 2408 | §103 | Non-Final OA | — | Pending | Jul 11, 2023 |
| 18260429 | IMAGE ANALYSIS AND NON-INVASIVE DATA COLLECTION FROM CELL CULTURE DEVICES | Celvivo Aps | KWAK, DEAN P | 1798 | §102§112Other | Final Rejection | — | Pending | Jul 05, 2023 |
| 18260079 | RECOMBINANT HUMAN HYALURONIDASE FORMULATION AND APPLICATION THEREOF | Shanghai Bao Pharmaceuticals Co., Ltd. | FAN, LYNN Y | 1759 | §103§112 | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18270472 | FORMULATIONS OF ANTI-CD73 ANTIBODIES | I-Mab Biopharma US Limited | CESARE, JOSEPH DAVID | 1675 | §103Other | Non-Final OA | 8d overdue | Pending | Jun 29, 2023 |
| 18259871 | Anti-FGFR2 Antibody and Use Thereof | Shenzhen Forward Pharmaceuticals Co., Limited | PETERS, ALEC JON | 1641 | §112DP | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18341714 | SYSTEMS AND METHODS FOR DISTRIBUTION MANAGEMENT INCLUDING SINGLE PANE OF GLASS USER INTERFACE | Ingram Micro Inc. | ZEROUAL, OMAR | 3628 | §101§103 | Non-Final OA | — | Pending | Jun 26, 2023 |
| 18268870 | STRUCTURAL DAMPER FOR PROTECTING STRUCTURES AGAINST VIBRATIONS AND STRUCTURE COMPRISING SUCH A STRUCTURAL DAMPER | Maurer Engineering GmbH | BURCH, MELODY M | 3616 | §102§103§112 | Non-Final OA | 22d | Pending | Jun 21, 2023 |
| 17926863 | NOVEL TRICYCLIC AROMATIC HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Shanghai Longwood Biopharmaceuticals Co., Ltd. | PECKHAM, RICHARD GRANT | 1627 | §112 | Final Rejection | — | Pending | May 22, 2023 |
| 18252788 | Acoustic Transponder, Use of an Acoustic Transponder, Method for Producing a Transponder, and Acoustic Transmission System | TDK Electronics AG | GORDON, BRYAN P | 2837 | §102§103 | Non-Final OA | — | Pending | May 12, 2023 |
| 18035279 | SOLID FORMULATION | Katholieke Universiteit Leuven | BAUER, BRIANNA LEE | 1623 | §103DP | Final Rejection | 2d overdue | Pending | May 03, 2023 |
| 18249209 | DOSING REGIMENS FOR CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS | Medic Life Sciences Inc. | HEITMEIER, KENDALL NICOLE | 1621 | §103§112Other | Final Rejection | 23d | Pending | Apr 14, 2023 |
| 17907394 | USE OF BERBERINE ANALOG AND JAK INHIBITOR IN TREATMENT OF INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACT | Shanghai Ennovabio Pharmaceuticals Co., Ltd. | RODRIGUEZ, RAYNA B | 1628 | §103 | Non-Final OA | 25d overdue | Pending | Apr 07, 2023 |
| 18127221 | DIFFUSER SECURED TO CONTAINER DRAWING OIL FRAGRANCE INTO DIFFUSER ELEMENT VIA CAPILLARY ACTION | Ulta-Lit Tree Company | PHAM, TUONGMINH NGUYEN | 3752 | §103§112 | Final Rejection | 32d overdue | Pending | Mar 28, 2023 |
| 18177723 | SHARING COMPONENTS AMONG APPLICATIONS METHOD FOR WEB APPLICATION DEVELOPMENT | Cloudblue LLC | DISTEFANO, GREGORY A | 2174 | §103§112 | Non-Final OA | — | Pending | Mar 02, 2023 |
| 18174463 | FIBER ARRAYS | Early Is Good, Inc. | ALABI, OYELEYE A | 1797 | §102§103 | Final Rejection | 8d overdue | Pending | Feb 24, 2023 |
| 18040570 | NEW THIOUREA-BASED COMPOUNDS, PRODUCTION METHOD AND USE THEREOF TO DETECT GHB IN BEVERAGES | UNIVERSITAT DE VALÈNCIA | ADAMS, MICHELLE | 1797 | §112 | Non-Final OA | — | Pending | Feb 03, 2023 |
| 18104486 | FEED MIXER WITH MIXING AUGER HAVING AN UPWARD INCREASING PITCH | Trioliet B.V. | COOLEY, CHARLES E | 1774 | §102§103§112 | Non-Final OA | 22d | Pending | Feb 01, 2023 |
| 18076859 | METHOD FOR ARBITRATING ENCRYPTED ELECTRONIC TRANSACTIONS AMONG INTERMEDIARY AND AUTHORING USERS ONLY WHEN AN INTERACTION OCCURS BETWEEN AUTHORING AND CANDIDATE USERS WHO WAS EXPOSED BY THE INTERMEDIARY USER TO DATA PUBLISHED BY AUTHORING USER | Aliro Group Inc. | BARGEON, BRITTANY E | 3688 | §101§103§112 | Final Rejection | — | Pending | Dec 07, 2022 |
| 17998234 | COMPOUNDS AS BCL-2 INHIBITORS | Fochon Biosciences, Ltd. | STOCKTON, LAURA LYNNE | 1626 | §112DP | Non-Final OA | 22d | Pending | Nov 08, 2022 |
| 17906435 | Modified Red Blood Cells and Uses Thereof for Delivering Agents | Westlake Therapeutics (Hangzhou) Co. Limited | STEADMAN, DAVID J | 1656 | §103§112DP | Non-Final OA | — | Pending | Sep 15, 2022 |
| 17760394 | Antibodies Conjugated with Fatty Acid Molecules and Uses Thereof | Phanes Therapeutics, Inc. | MELCHIOR, JAMES RYLAND | 1644 | §103§112DP | Non-Final OA | 37d overdue | Pending | Aug 09, 2022 |
| 17758048 | Method For Constructing Gene Mutation Library | Nanjing Genscript Biotech Co., Ltd. | FLINDERS, JEREMY C | 1684 | §103 | Non-Final OA | 8d | Pending | Jun 27, 2022 |
| 17757801 | PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF | Asieris Pharmaceuticals (Shanghai) Co., Ltd. | LEE, SIN J | 1613 | §103§112 | Non-Final OA | 73d overdue | Pending | Jun 21, 2022 |
| 17843055 | DEVICES AND METHODS FOR PREPARING A SLURRY AND COATING A SUBSTRATE WITH A SLURRY | Inition Energy Ltd. | TADESSE, YEWEBDAR T | 1717 | §103§112 | Final Rejection | 70d | Pending | Jun 17, 2022 |
| 17839166 | ROLLING SHUTTER SYSTEM | Qualitas Manufacturing Incorporated | SHEPHERD, MATTHEW RICHARD | 3634 | §103 | Non-Final OA | 12d | Pending | Jun 13, 2022 |
| 17636771 | PROCESS FOR PRODUCING A PORE-CONTAINING GRANULATE AND A PORE-CONTAINING ARTIFICIAL STONE | Rekers GmbH Maschinen- Und Anlagenbau | CHAU, LISA N | 1785 | §102§103 | Non-Final OA | — | Pending | Feb 18, 2022 |
| 17632521 | PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE ORAL SOLID TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Yahong Meditech Co., Ltd. | STEINKE, SEAN JAMES | 1619 | §102§103Other | Non-Final OA | — | Pending | Feb 03, 2022 |
| 17589043 | ELECTROCAUTERY APPARATUS AND METHOD FEATURING ULTRASOUND GUIDANCE | Little Engine LLC | ZIEGLER, ABIGAIL M | 3794 | §103§112 | Non-Final OA | — | Pending | Jan 31, 2022 |
| 17559978 | METHODS OF PURIFYING CHARGE-SHIELDED FUSION PROTEINS | Pfenex, Inc. | EDWARDS, JESSICA FAYE | 1657 | §103 | Final Rejection | 23d overdue | Pending | Dec 22, 2021 |
| 17593989 | ANTI-HER2 BISPECIFIC ANTIBODY AND APPLICATION THEREOF | Shanghai Bao Pharmaceuticals Co., Ltd. | EDGINGTONGIORDANO, FRANCESCA | 1643 | §112 | Non-Final OA | — | Pending | Sep 29, 2021 |
| 17442115 | CAR-T-CELL THERAPY | Ab2 Bio SA | ZHU, JIANJIAN | 1631 | DP | Final Rejection | 23d overdue | Pending | Sep 22, 2021 |
| 17437968 | METHOD FOR SCREENING COMPOUND FOR TREATING OR PREVENTING POLYQ-RELATED NEURODEGENERATIVE DISEASES | Fudan University | WANG, CHANG YU | 1675 | §112 | Non-Final OA | — | Pending | Sep 10, 2021 |
| 17419569 | OLIGOMERIC NUCLEIC ACID MOLECULE AND APPLICATION THEREOF | Ractigen Therapeutics | TRAN, CHRISTINA L | 1637 | §103 | Final Rejection | 73d overdue | Pending | Jun 29, 2021 |
| 17297104 | ELECTRON BEAM CURABLE WATER-BASEDINK-JET INK COMPOSITION | Sakata Inx Corporation | BARZACH, JEFFREY EUGENE | 1731 | §103 | Non-Final OA | 26d | Pending | May 26, 2021 |
| 17250791 | METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | TRAN, KHOA NHAT | 1632 | §103§112 | Final Rejection | — | Pending | Mar 04, 2021 |
| 17260000 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | Hifibio SAS | THOMPSON, CURTIS A | 1798 | §103Other | Non-Final OA | 5d overdue | Pending | Jan 13, 2021 |
| 17259992 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | Ecole Supérieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) | THOMPSON, CURTIS A | 1798 | §103Other | Non-Final OA | 5d overdue | Pending | Jan 13, 2021 |
| 16767920 | METHODS OF TREATMENT WITH ASPARAGINASE | Jazz Pharmaceuticals Ireland Limited | ROBINSON, HOPE A | 1652 | §103 | Non-Final OA | 34d | Pending | May 28, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial